Skip to main content
Fig. 2 | Health and Quality of Life Outcomes

Fig. 2

From: The negative impact of spasticity on the health-related quality of life of stroke survivors: a longitudinal cohort study

Fig. 2

Adjusted mean EuroQol-5 dimension (EQ-5D) scores by patient-reported spasticity presence. Significantly lower EQ-5D scores were reported by survivors with spasticity than those without spasticity at 3 months (mean difference −0.12; 95 % confidence interval [CI] –0.18 to −0.06; P < .001), at 1 year (mean difference −0.12; 95 % CI −0.19 to −0.06; P < .001), and at 2 years (mean difference −0.08; 95 % CI −0.16 to −0.0004; P = .049) poststroke. Scores were adjusted for age, race, stroke severity using the retrospective National Institute of Health Stroke Scale, prestroke function using the modified Rankin Scale, and comorbidities

Back to article page